CVS Health (CVS) Opens New Pharmacy Sites As Undervalued Narrative Holds - Yahoo Finance Singapore
Article excerpt
Highlighted: the sentence this signal was extracted from
CVS Health (CVS) is expanding its pharmacy-focused format by opening nearly 20 smaller neighborhood locations across the US in 2026, including a new Roxbury site in the Boston area. Recent headlines around CVS Health have mixed signals for investors, with Medicare Advantage star rating setbacks and a legal probe weighing on sentiment, while the extended Cardinal Health distribution deal and a reaffirmed dividend provide a steadier backdrop. Even after a one-day share price decline of 1.87% and a 30-day share price return down 8.98%, the year-to-date share price return of 7.53% and a one-year total shareholder return of 14.11% indicate that longer term holders have still seen gains as shorter term momentum has faded. Spot 29 high quality undervalued stocks that, like CVS Health, combine sizeable healthcare exposure with established cash generation and could be setting up for the next phase of their rerating. That mix of headline pressure and steady cash generation has hit CVS Health's share price, but sentiment can move faster than fundamentals. Is this pullback a reset of expectations, or a misread of what the business is worth? On the most followed view, CVS Health screens as undervalued, with a fair value of $124 against a last close of $86.16, which frames the latest pullback as more than just headline fatigue. CVS Health is no longer the broken-Aetna-plus-drugstore story...
Keep reading with a free account
The rest of this article, and every signal for CVS, is in your free account.
